Computational Eurotransplant kidney allocation simulations demonstrate the feasibility and benefit of T-cell epitope matching.

by Matthias Niemann, Nils Lachmann, Kirsten Geneugelijk, Eric Spierings
Published 2021-07-01

Can PIRCHE-II Matching Outmatch Traditional HLA Matching?

by Christian Unterrainer, Bernd Döhler, Matthias Niemann, Nils Lachmann, Caner Süsal
Published 2021-02-01

Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step

by Nils Lachmann, Michael Duerr, Constanze Schönemann, Axel Pruß, Klemens Budde, Johannes Waiser
Published 2017-01-01

MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.

by Mareen Matz, Frederik Heinrich, Christine Lorkowski, Kaiyin Wu, Jens Klotsche, Qiang Zhang, Nils Lachmann, Pawel Durek, Klemens Budde, Mir-Farzin Mashreghi
Published 2018-01-01

Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles

by Lukas J. Lehner, Arnim Hohberger, Lisanne Marschke, Nils Lachmann, Robert Peters, Frank Friedersdorff, Dmytro Khadzhynov, Fabian Halleck, Klemens Budde, Oliver Staeck, Michael Duerr
Published 2020-09-01

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept

by Mira Choi, Friederike Bachmann, Kaiyin Wu, Nils Lachmann, Danilo Schmidt, Susanne Brakemeier, Michael Duerr, Andreas Kahl, Kai-Uwe Eckardt, Klemens Budde, Peter Nickel
Published 2020-08-01

Serum Selenium Status as a Diagnostic Marker for the Prognosis of Liver Transplantation

by Safak Gül-Klein, Deana Haxhiraj, Julian Seelig, Anika Kästner, Julian Hackler, Qian Sun, Raban Arved Heller, Nils Lachmann, Johann Pratschke, Moritz Schmelzle, Lutz Schomburg
Published 2021-02-01

Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation

by Sinem Ünlü, Nils Lachmann, Maximilian Jara, Paul Viktor Ritschl, Leke Wiering, Dennis Eurich, Christian Denecke, Matthias Biebl, Sascha Chopra, Safak Gül-Klein, Wenzel Schöning, Moritz Schmelzle, Petra Reinke, Frank Tacke, Johann Pratschke, Robert Öllinger, Tomasz Dziodzio
Published 2020-12-01

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial

by Farsad Eskandary, Michael Dürr, Klemens Budde, Konstantin Doberer, Roman Reindl-Schwaighofer, Johannes Waiser, Markus Wahrmann, Heinz Regele, Andreas Spittler, Nils Lachmann, Christa Firbas, Jakob Mühlbacher, Gregor Bond, Philipp F. Halloran, Edward Chong, Bernd Jilma, Georg A. Böhmig
Published 2019-01-01